Premium
Letter: PPI vs. teprenone in preventing recurrence of ulcers during low‐dose aspirin – authors’ reply
Author(s) -
Iwakiri R.,
Fujimoto K.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12995
Subject(s) - esomeprazole , medicine , rabeprazole , gastroenterology , lansoprazole , cyp2c19 , aspirin , helicobacter pylori , placebo , peptic , clinical trial , proton pump inhibitor , peptic ulcer , randomized controlled trial , pathology , alternative medicine , cytochrome p450 , metabolism